5 
one agency, noting a possible violation in the regulatory domain of 
another agency, make the appropriate referral. 
Dr. Hunt described EPA's regulatory authorities and 
Dr. Banks noted that EPA has recently issued a solicitation for 
grant proposals, including studies of the potential impact of new 
genomes introduced into established ecosystems. 
Dr. McCracken spoke of the great promise of recombinant DNA 
technology for agriculture. 
Next Subcommittee Meeting 
Dr. Omenn reminded the Subcommittee of Dr. Fredrickson's 
request for a final report by the autumn. Dr. Robbins said that 
NIOSH and OSHA staff would be contacting Subcommittee members and 
other staff of the agencies, over the next, months, to ask for 
further information and for review of drafts. He requested a wait 
of about two months before the next Subcommittee meeting so that 
NIOSH could visit more industrial facilities and prepare its 
recommendations for presentation to the Subcommittee. Dr. Goldberg 
noted that FDA will be sponsoring a State of the Art Conference on 
Insulins and Growth Hormone, to be held at NIH on June 3 and 4. 
It was agreed to schedule the next Subcommittee meeting for after 
that date. Dr. Omenn asked if the Subcommittee should sponsor a 
public meeting. It was agreed that rather than have a large, 
open, public meeting, the next Subcommittee meeting, in June, 
would consist of 1 to 1% hours of hearing from no more than six 
invited representatives of labor, industry, and/or science, to be 
immediately followed by another 1% hour meeting of just the 
[ 351 ] 
